MedPath

江西青峰药业有限公司

Ownership
-
Established
2001-12-12
Employees
-
Market Cap
-
Website
www.qfyy.com.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

105

NMPA:105

Drug Approvals

Eribulin Mesilate Injection

Product Name
甲磺酸艾立布林注射液
Approval Number
国药准字H20253131
Approval Date
Jan 14, 2025
NMPA

Methocarbamol Injection

Product Name
美索巴莫注射液
Approval Number
国药准字H20249039
Approval Date
Oct 9, 2024
NMPA

Entecavir

Product Name
恩替卡韦
Approval Number
国药准字H20100140
Approval Date
Jul 4, 2024
NMPA

穿心莲片

Approval Number
国药准字Z36021074
Approval Date
Jul 1, 2024
NMPA

慈航片

Approval Number
国药准字Z20026965
Approval Date
Jul 1, 2024
NMPA

Enzalutamide Soft Capsules

Product Name
恩扎卢胺软胶囊
Approval Number
国药准字H20244129
Approval Date
Jun 25, 2024
NMPA

Mecobalamin

Product Name
甲钴胺
Approval Number
国药准字H20041313
Approval Date
May 10, 2024
NMPA

Magnesium Sulfate Injection

Product Name
硫酸镁注射液
Approval Number
国药准字H20243104
Approval Date
Jan 30, 2024
NMPA

Lacosamide Tablets

Product Name
拉考沙胺片
Approval Number
国药准字H20193021
Approval Date
Jan 15, 2024
NMPA

Lacosamide Tablets

Product Name
拉考沙胺片
Approval Number
国药准字H20193022
Approval Date
Jan 15, 2024
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 11
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.